GSK.L
GSK PLC ORD 31 1/4P
Healthcare · in the FTSE 100
📍 London, United Kingdom · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
Key figures, against the FTSE 100
Figures as of 5 Nov 2026, refreshed weekly
Each bar places this company among the FTSE 100 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
17.3x
The share price is 17.3 times the last twelve months' earnings per share.
P/E on average earnings?
17.3x
The share price is 17.3 times earnings per share averaged over recent years.
Price / book
4.6x
The market values the company at 4.6 times the accounting value of its equity.
EV / EBIT?
11.9x
The company's value including its debt is 11.9 times its operating profit.
Free cash flow yield?
7.1%
Free cash flow equals 7.1% of the company's market value.
Profitability
Return on equity?
28.3%
Each 100 of shareholders' money produced 28.3 of net profit.
Return on assets?
9.2%
Each 100 of assets produced 9.2 of net profit.
Return on invested capital
20.7%
Each 100 invested by lenders and owners produced 20.7 of profit.
Operating margin?
24.8%
Of every 100 in sales, 24.8 was left as operating profit.
Debt
Debt / equity?
129.6%
Total debt equals 130% of shareholders' equity.
Net debt / EBITDA?
1.9x
Net debt equals 1.9 years of operating earnings (EBITDA).
Interest cover
11.8x
Operating profit was 11.8 times the interest bill.
Growth
Revenue growth
7.7%
Latest revenue is 7.7% above the average of earlier reported years.
Earnings growth
45.8%
Latest net profit is 45.8% above the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.